Greg Lucas - Nephros President Systems
| NEPH Stock | USD 1.63 0.02 1.24% |
President
Greg Lucas is President Systems of Nephros
| Address | 380 Lackawanna Place, South Orange, NJ, United States, 07079 |
| Phone | 201 343 5202 |
| Web | https://www.nephros.com |
Nephros Management Efficiency
The company has return on total asset (ROA) of (0.0796) % which means that it has lost $0.0796 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1561) %, meaning that it created substantial loss on money invested by shareholders. Nephros' management efficiency ratios could be used to measure how well Nephros manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.16. The current Return On Capital Employed is estimated to decrease to -0.17. As of now, Nephros' Asset Turnover is increasing as compared to previous years.Similar Executives
| Found 7 records | PRESIDENT Age | ||
| Nicolai Andersen | Coloplast A | 54 | |
| Paul Marcun | Coloplast A | 56 | |
| Divaker Mangadu | Precision Optics, | N/A | |
| Alain Morvan | Coloplast A | N/A | |
| Guillaume Daniellot | Straumann Holding AG | 53 | |
| James McAvinn | Milestone Scientific | N/A | |
| Anders LonningSkovgaard | Coloplast A | 51 | |
Management Performance
| Return On Equity | -0.16 | ||||
| Return On Asset | -0.0796 |
Nephros Leadership Team
Elected by the shareholders, the Nephros' board of directors comprises two types of representatives: Nephros inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nephros. The board's role is to monitor Nephros' management team and ensure that shareholders' interests are well served. Nephros' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nephros' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Vashone Thomas, Regulatory, Quality | ||
| Daron Evans, CEO and President Acting CFO, Director and Member of Audit Committee | ||
| Joleen Turner, VP Devel | ||
| Judy CFA, Chief Officer | ||
| Judy Mazzini, Controller | ||
| MS MBA, Inc Products | ||
| Andrew Astor, CFO, CEO | ||
| Greg Lucas, President Systems | ||
| Robert Banks, CEO President | ||
| Alfred Vargas, Director Operations | ||
| Brianne McGuire, Marketing Brand |
Nephros Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nephros a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.16 | ||||
| Return On Asset | -0.0796 | ||||
| Profit Margin | (0.09) % | ||||
| Operating Margin | (0.1) % | ||||
| Current Valuation | 15.38 M | ||||
| Shares Outstanding | 10.54 M | ||||
| Shares Owned By Insiders | 12.70 % | ||||
| Shares Owned By Institutions | 40.92 % | ||||
| Number Of Shares Shorted | 7.69 K | ||||
| Price To Earning | (4.51) X |
Currently Active Assets on Macroaxis
When determining whether Nephros offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nephros' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nephros Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nephros Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nephros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Household Appliances space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Revenue Per Share 1.313 | Quarterly Revenue Growth (0.08) | Return On Assets (0.08) | Return On Equity (0.16) |
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.